Lindholm JM, et al. - In this prospective non-randomized controlled clinical trial, researchers sought to determine the efficacy, safety, and tolerability of a single perioperative subconjunctival injection of triamcinolone acetonide (TA) vs steroid drops for the prevention of macular edema and ocular inflammation after cataract surgery. Among the studied 101 eyes of 101 patients who had elective cataract surgery at Kymenlaakso Central Hospital, Kotka, Finland, 50 eyes received conventional postoperative care with dexamethasone 1 mg/ml eye drops, and 51 eyes received a perioperative 20 mg subconjunctival injection of TA. Outcomes support the effectiveness of perioperative subconjunctival TA in preventing ocular inflammation and macular edema following cataract surgery. For dropless postoperative care in modern cataract surgery, they recognized subconjunctival TA combined with intracameral cefuroxime as a noteworthy option.